Issued Patents 2022
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11498971 | BCMA (CD269) specific chimeric antigen receptors for cancer immunotherapy | — | 2022-11-15 |
| 11414674 | Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells | Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Laurent POIROT, Andrew M. Scharenberg +1 more | 2022-08-16 |
| 11396551 | Chimeric antigen receptors targeting CD70 | Surabhi Srivatsa Srinivasan, Niranjana Nagarajan, Siler PANOWSKI, Yoon Kyung Park, Tao Sai +3 more | 2022-07-26 |
| 11312782 | Chimeric antigen receptors targeting B-cell maturation antigen | Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Philippe Duchateau, Alexandre Juillerat +6 more | 2022-04-26 |
| 11311575 | Methods for engineering highly active T cell for immunotherapy | Agnes Gouble, Stephanie GROSSE, Cécile SCHIFFER-MANNIOUI, Laurent POIROT, Andrew M. Scharenberg +1 more | 2022-04-26 |
| 11304975 | Methods for engineering allogeneic and highly active t cell for immunotherapy | Agnes Gouble, Stephanie GROSSE, Cécile SCHIFFER-MANNIOUI, Laurent POIROT, Andrew M. Scharenberg +1 more | 2022-04-19 |
| 11274316 | Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells | Agnes Gouble, Stephanie GROSSE, Cecile Mannioui, Laurent POIROT, Andrew M. Scharenberg +1 more | 2022-03-15 |